This provider's $6.7M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 93% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $769.90 | $214.68 | 3.59x | $555.22 | $541.7K | 1.2K | 1.1K |
| 2015 | $891.61 | $252.15 | 3.54x | $639.46 | $418.7K | 885 | 839 |
| 2016 | $1.2K | $311.78 | 3.78x | $867.28 | $536.4K | 1.1K | 1.0K |
| 2017 | $943.67 | $239.85 | 3.93x | $703.82 | $556.1K | 1.2K | 1.1K |
| 2018 | $1.1K | $331.75 | 3.42x | $803.56 | $708.9K | 1.0K | 958 |
| 2019 | $1.2K | $313.60 | 3.85x | $894.95 | $735.2K | 1.2K | 1.1K |
| 2020 | $1.9K | $590.69 | 3.22x | $1.3K | $610.0K | 755 | 714 |
| 2021 | $2.3K | $977.97 | 2.35x | $1.3K | $820.0K | 894 | 839 |
| 2022 | $1.9K | $595.22 | 3.27x | $1.3K | $758.3K | 876 | 843 |
| 2023 | $1.7K | $516.45 | 3.25x | $1.2K | $1.0M | 1.2K | 1.1K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 2.9K | $3.8M | $1.3K | 3.80x |
| 78816 | Nuclear medicine study with CT imaging whole body | 1.1K | $1.6M | $1.4K | 3.70x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3.3K | $780.2K | $236.05 | 1.32x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 248 | $112.3K | $452.96 | 1.28x |
| 78306 | Bone and/or joint imaging, whole body | 352 | $76.5K | $217.24 | 2.67x |
| A9597 | Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified | 18 | $66.2K | $3.7K | 1.25x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 122 | $39.8K | $326.00 | 1.48x |
| 78195 | Imaging of lymphatic tissue and lymph node | 87 | $28.5K | $328.05 | 2.76x |
| 78813 | Nuclear medicine imaging whole body | 20 | $27.2K | $1.4K | 3.87x |
| 71260 | CT scan chest with contrast | 173 | $24.5K | $141.90 | 5.18x |
| A9572 | Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries | 12 | $23.6K | $2.0K | 1.34x |
| 74177 | CT scan of abdomen and pelvis with contrast | 73 | $22.1K | $302.53 | 4.34x |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 124 | $18.4K | $148.03 | 1.49x |
| 78803 | Nuclear medicine study of radioactive material distribution | 121 | $18.0K | $148.66 | 5.07x |
| 78264 | Stomach emptying study | 60 | $16.5K | $274.44 | 2.30x |
| 78320 | Nuclear medicine study of bone and/or joint | 103 | $12.4K | $120.70 | 5.20x |
| A9561 | Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | 276 | $11.7K | $42.34 | 1.28x |
| 78582 | Nuclear medicine study of lung ventilation and blood circulation in the lungs | 37 | $11.6K | $314.74 | 4.67x |
| 78807 | Nuclear medicine study of radioactive material distribution at site of inflammation | 36 | $11.5K | $318.91 | 7.34x |
| 79445 | Radioactive material therapy into artery | 110 | $11.1K | $101.01 | 4.77x |
This provider submits charges 3.4 times higher than what Medicare actually pays.
A markup ratio of 3.4x means for every $100 Medicare pays, this provider initially charges $340. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data